Latest news
Loading news…
GlycoFi
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Hanover, New Hampshire, United States Founded 2000 101-250 employees For Profit
GlycoFi is a bio tech firm that develops bio-therapeutics based on the glycan optimization technology.
GlycoFi was acquired by Merck in 2006 for $400M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- IT spend
- $9M
Company Info
- Founded
- 2000
- Employees
- 101-250
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Hanover, New Hampshire, United States
- Region
- East Coast, New England, Northeastern US
- Exit date
- May 9, 2006
- Closed
- Aug 5, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -2.1
- Trend (90d)
- -0.4
Key People at GlycoFi
Co - Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to GlycoFi
Loading news…
FAQs about GlycoFi
People who checked this page also checked these
Browse the full Acquirezy directory.